SCHEMBL13670010

SCHEMBL13670010

Cc1cc(C(=O)N2CCC(N)CC2)no1

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.62
CHRNA4 P43681 2/20 0.56
MAPT P10636 2/20 0.53
ALDH1A1 P00352 3/20 0.52
TSHR P16473 2/20 0.52
GPR6 P46095 1/20 0.49
CYP2D6 P10635 1/20 0.48
HRH3 Q9Y5N1 1/20 0.48
THRB P10828 2/20 0.48
KDM4E B2RXH2 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
TP53 P04637 1/20 0.45
HPGD P15428 1/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2606197 0.86 NPC1 (0.60) KMT2ACHRNA4MAPTALDH1A1TSHR
SCHEMBL2603239 0.82 KMT2A (0.56) KMT2ACHRNA4MAPTALDH1A1TSHR
SCHEMBL25676108 0.82 KMT2A (0.56) KMT2ACHRNA4MAPTALDH1A1TSHR
SCHEMBL13631422 0.82 KMT2A (0.66) KMT2ACHRNA4MAPTALDH1A1TSHR
SCHEMBL23573417 0.81 KMT2A (0.54) KMT2ACHRNA4MAPTALDH1A1TSHR
SCHEMBL1082421 0.80 KMT2A (0.56) KMT2ACHRNA4MAPTALDH1A1TSHR
SCHEMBL1023268 0.80 KMT2A (0.53) KMT2ACHRNA4MAPTALDH1A1TSHR
SCHEMBL4336905 0.80 KMT2A (0.53) KMT2ACHRNA4MAPTALDH1A1TSHR
SCHEMBL2360551 0.80 KMT2A (0.62) KMT2ACHRNA4MAPTALDH1A1TSHR
SCHEMBL18483472 0.80 KMT2A (0.67) KMT2ACHRNA4MAPTALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009132202-A2 MACROCYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS INCYTE CORPORATION (US) 2009-10-29 WO disclosed